Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Omicron Biochemicals is a specialized biotechnology company that focuses on the synthesis of stable isotope-labeled compounds for biomedical research. Founded in 1982 and based in South Bend, Indiana, the company is a leading provider of carbohydrates, nucleosides, and their derivatives labeled with 13C, 15N, 2H, and 18O. Their products are essential for researchers using NMR spectroscopy and mass spectrometry to study metabolic pathways and molecular structures. Omicron Biochemicals serves a global clientele in academia, government, and the pharmaceutical industry. The company is particularly recognized for its expertise in site-specific labeling of complex biomolecules.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Omicron Biochemicals.